SB 912 inserts comprehensive perinatal services into California’s Medi‑Cal schedule of benefits and signals the Department of Health Care Services (DHCS) to pursue any federal approvals needed to pay for those services with Medicaid matching funds. The bill makes perinatal coverage contingent on obtaining federal waivers or other approvals and on the availability of federal financial participation.
Beyond perinatal care, the statutory text the bill sets forth also reaffirms or clarifies several existing program elements in the Medi‑Cal schedule — including the Family PACT family‑planning program, coverage of home test kits for STDs, Rapid Whole Genome Sequencing for certain infants, and a facility for nonmedical transportation — each with conditions tied to federal approvals, utilization controls, and coding or reimbursement requirements. For providers and payers, the practical effect is new, potentially expanded benefit eligibility that cannot be implemented unless federal matching funds and any required CMS approvals are secured.
At a Glance
What It Does
The bill adds a statutory item to the Medi‑Cal benefits schedule that requires DHCS to provide comprehensive perinatal services through agreements with designated providers and according to department standards, but only to the extent federal waivers and Medicaid matching funds are available. It also codifies related coverage items (Family PACT, home STD test kits, Rapid WGS for infants, nonmedical transportation, and violence‑prevention services), typically subject to utilization review and federal approval.
Who It Affects
Low‑income pregnant and postpartum people enrolled in Medi‑Cal and clinics designated under Section 14134.5 are directly affected; Medi‑Cal managed care plans, fee‑for‑service billing systems, and DHCS program and waiver staff must implement benefit, coding, and payment changes. Providers delivering family planning, perinatal, neonatal genetics, and community violence‑prevention services will face new contracting, documentation, and utilization‑control requirements.
Why It Matters
The bill creates a pathway to expand perinatal and adjacent services under Medi‑Cal but makes expansion conditional on federal participation and waiver approvals, which means practical access will hinge on DHCS’s ability to secure matching funds and CMS sign‑offs. For compliance officers and payers, the text signals likely future billing, coding, and utilization‑review changes tied to federal rules.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 912 places comprehensive perinatal services into the Medi‑Cal schedule of covered benefits and instructs the Department of Health Care Services to implement those services through agreements with designated providers who meet department standards. The statute does not deliver an immediate new entitlement; instead it conditions implementation on DHCS obtaining any necessary federal waivers and on the availability of Medicaid matching funds.
If federal approval cannot be obtained for particular elements, DHCS must not implement those elements, and provisions without matching funds remain dormant.
The statutory text in the bill bundles perinatal coverage with a set of other specified benefits and operational rules already present in the Medi‑Cal schedule: a Family PACT family‑planning program with an income threshold, coverage mechanics for home STD test kits tied to CLIA/FDA requirements and CPT/HCPCS coding, a discrete benefit for Rapid Whole Genome Sequencing for infants in intensive care, and expanded language on nonmedical transportation and violence‑prevention services. Each of these items carries gating language — utilization controls, coding requirements, or the need for federal financial participation — that will shape whether and how DHCS can roll the benefit out.Operationally, the bill requires DHCS to align implementation with federal guidance and to use administrative tools (all‑county letters, plan or provider bulletins, policy letters) to act quickly where permitted, while reserving formal rulemaking for when regulations are required.
That dual approach means DHCS can publish interim instructions to providers and managed care plans, but long‑term program structure, reimbursement rates, and utilization‑management policies will likely be finalized in subsequent regulations or waiver documents. For provider organizations and managed care plans, key immediate tasks will be readiness for new contracting models for perinatal providers, updates to billing codes (especially for home test kits and WGS), and preparation for utilization‑review frameworks tied to medical necessity standards.
The Five Things You Need to Know
SB 912 makes comprehensive perinatal services a Medi‑Cal covered benefit delivered through agreements with providers designated under Section 14134.5, but explicitly limits implementation to the extent federal waivers and Medicaid matching funds are available.
The department must seek any necessary federal approvals to implement perinatal provisions and may only implement provisions for which waivers are obtained or for which waivers are not required; elements lacking federal approval will not be put into effect.
The bill preserves and governs the Family PACT program as a state program providing clinical family planning services to people at or below 200% of the federal poverty level and defines the program’s core services and administrative rules.
Rapid Whole Genome Sequencing (including trio and ultra‑rapid sequencing) is listed as a covered benefit for Medi‑Cal beneficiaries one year or younger receiving inpatient intensive care, but its implementation is contingent on any necessary federal approvals and funding availability.
Coverage of home test kits for STDs and reimbursement are permitted when ordered by enrolled clinicians and are contingent on CLIA/FDA status, addition of CPT/HCPCS codes, and federal financial participation; DHCS may use provider bulletins to implement interim policies.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Comprehensive perinatal services added to Medi‑Cal schedule with waiver and funding conditions
This subdivision identifies comprehensive perinatal services as an explicit Medi‑Cal benefit to be provided via agreements with providers designated under Section 14134.5 and according to department standards. Practically, DHCS must develop standards and negotiate agreements with specified providers, but the text places a hard dependency on federal waivers and Medicaid matching funds — meaning DHCS cannot implement components that lack CMS approval or matching funds. The language preserves DHCS discretion to seek waivers and to prioritize what to implement first based on approvals and funding.
Family PACT program — eligibility, scope, and federal alignment
The statute sets up a Family PACT program for people at or below 200% of the federal poverty level and directs DHCS to seek a Section 1315 waiver or a successor state plan amendment to operate the program with federal participation. It lists core clinical family‑planning services, counseling, culturally competent education, and administrative rules to be applied to the program, and gives DHCS authority to operate the program under waiver terms and to later convert to a successor state plan amendment. The subdivision also contains cost‑effectiveness and reporting triggers that can render the program inoperative if the Department of Finance determines it is not cost effective.
Rapid Whole Genome Sequencing for infants in intensive care
The text designates rapid whole genome sequencing (individual, trio, and ultra‑rapid) as a covered Medi‑Cal benefit for beneficiaries one year of age or younger receiving inpatient ICU care no sooner than January 1, 2022. DHCS may implement this coverage via interim instructions prior to formal regulation, but only to the extent federal approvals and financial participation are in place. Administrators and neonatal providers will need to reconcile this benefit with existing pediatric genetic policies and lab reimbursement mechanisms.
Home test kits for STDs — clinical, coding, and reimbursement conditions
The bill authorizes coverage of home test kits for STDs (including HIV) when medically appropriate and ordered by an enrolled Medi‑Cal clinician or issued via standing order. It defines acceptable kits by CLIA waiver and FDA clearance or laboratory development standards, and makes reimbursement contingent on the existence of CPT/HCPCS codes and sending specimens to Medi‑Cal‑enrolled labs with fees aligned to Medicare rules. This links clinical policy to billing infrastructure and HIPAA‑compliant coding, delaying payment until codes and lab pathways are established.
Nonmedical transportation parameters and managed care obligations
The subdivision clarifies that nonmedical transportation to obtain covered Medi‑Cal services is covered subject to utilization controls, specifying modes (private vehicle mileage, bus passes, taxi vouchers) and exclusions (ambulance and wheelchair van for incapacitated patients). It requires managed care plans to provide nonmedical transportation to their enrollees and sets accessibility expectations consistent with disability law. Federal approvals and financial participation must be secured before full implementation.
Violence‑prevention services defined and conditioned on federal participation
SB 912 defines violence‑prevention services as evidence‑based, trauma‑informed, culturally responsive preventive services intended to reduce violent injury and related harms, and makes them payable subject to medical necessity and utilization controls. DHCS may implement these services by administrative instruction pending regulation, but only if federal approvals and funding permit. The subdivision requires DHCS to post the date when these services may be billed, creating a public trigger for operational readiness.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pregnant and postpartum Medi‑Cal beneficiaries: they gain an explicit statutory pathway to perinatal services that, if implemented, would expand access to prenatal, postpartum, and related supports under Medi‑Cal.
- Designated perinatal providers and community clinics: providers meeting Section 14134.5 standards could contract with DHCS to deliver perinatal services and obtain Medi‑Cal reimbursement for a broader set of perinatal interventions.
- Low‑income people seeking family planning (Family PACT eligible): the bill preserves a framework for comprehensive family‑planning services up to 200% FPL with a defined package of counseling, methods, and follow‑up.
- Neonatal and genetic services providers: NICU patients under one year could access Rapid Whole Genome Sequencing reimbursement, enabling earlier genetic diagnosis and potential care changes where implemented.
- Communities affected by violence: evidence‑based, trauma‑informed violence‑prevention services receive statutory standing for Medi‑Cal coverage, creating a funding pathway for upstream interventions.
Who Bears the Cost
- Department of Health Care Services (DHCS): DHCS must negotiate waivers, draft standards, issue provider guidance, and update payment systems — administrative and technical costs that may require budget requests.
- Medi‑Cal managed care plans: plans are assigned responsibility for nonmedical transportation for enrollees and will need to incorporate new benefits, utilization controls, and possibly vendor arrangements for transportation and home test kit distribution.
- State and federal budgets/taxpayers: expansion of benefits is conditioned on federal matching funds, but if DHCS secures waivers, state spending and budget offsets will need to be identified and appropriated.
- Clinical laboratories and providers: laboratories must adopt CLIA‑waived workflows and accept home‑test specimens from providers, and providers must adapt to new coding, documentation, and utilization‑review rules to secure reimbursement.
- County public health and community‑based organizations: those asked to deliver perinatal or violence‑prevention contracts may face upfront operational costs and new reporting requirements even where reimbursement is later available.
Key Issues
The Core Tension
SB 912 balances two legitimate objectives — expanding perinatal and related supports for low‑income Californians, and protecting program solvency and federal compliance by conditioning implementation on CMS approvals and Medicaid funding; the tension is that the gating language that preserves fiscal and federal compliance also creates uncertainty and potential access gaps for the very populations the bill intends to help.
The most salient implementation constraint in SB 912 is its dependency on federal approvals and Medicaid matching funds. That creates a two‑dimensional gate: DHCS must both secure CMS buy‑in for specific service constructs and align state budget authority to provide the state share.
The result is likely to be staged or partial rollouts, where some elements (those requiring no federal action) can proceed by administrative letter, while others will remain dormant until waiver negotiations conclude. This staggered approach risks geographic and population‑level disparities in access depending on how DHCS phases implementation and which providers are first contracted.
The bill also relies heavily on utilization controls, medical‑necessity review, and existing program administration to curb costs. Those mechanisms protect fiscal exposure but risk limiting timely access to services (for example, prompt perinatal supports or immediate deployment of home STD test kits).
The requirement that home test kits and Rapid WGS be tied to specific coding and lab payment systems creates an implementation dependency that is administrative rather than clinical — if codes are slow to arrive or lab networks are not prepared, clinical access can be delayed even when policy says the service is covered. Finally, the Family PACT cost‑effectiveness trigger and the “no additional net program costs” language for hospice are fiscal safety valves that could terminate or restrict services after implementation, introducing programmatic uncertainty into what otherwise reads like a benefits expansion.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.